Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other Operating Expenses: 2019-2024

Historic Other Operating Expenses for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $110.9 million.

  • Harmony Biosciences Holdings' Other Operating Expenses rose 7.15% to $29.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.9 million, marking a year-over-year increase of 7.02%. This contributed to the annual value of $110.9 million for FY2024, which is 13.87% up from last year.
  • According to the latest figures from FY2024, Harmony Biosciences Holdings' Other Operating Expenses is $110.9 million, which was up 13.87% from $97.4 million recorded in FY2023.
  • Over the past 5 years, Harmony Biosciences Holdings' Other Operating Expenses peaked at $110.9 million during FY2024, and registered a low of $55.8 million during FY2020.
  • Over the past 3 years, Harmony Biosciences Holdings' median Other Operating Expenses value was $97.4 million (recorded in 2023), while the average stood at $95.9 million.
  • Data for Harmony Biosciences Holdings' Other Operating Expenses shows a peak YoY grew of 25.96% (in 2020) over the last 5 years.
  • Over the past 5 years, Harmony Biosciences Holdings' Other Operating Expenses (Yearly) stood at $55.8 million in 2020, then increased by 22.02% to $68.1 million in 2021, then climbed by 16.39% to $79.3 million in 2022, then climbed by 22.85% to $97.4 million in 2023, then increased by 13.87% to $110.9 million in 2024.